↓ Skip to main content

Dove Medical Press

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, February 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
1 X user
reddit
1 Redditor

Readers on

mendeley
11 Mendeley
Title
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, February 2021
DOI 10.2147/dmso.s289446
Pubmed ID
Authors

Kaori Hisanaga, Hiroshi Uchino, Naoko Kakisu, Masahiko Miyagi, Fukumi Yoshikawa, Genki Sato, Kazutoshi Isobe, Kazuma Kishi, Sakae Homma, Takahisa Hirose

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 18%
Researcher 2 18%
Other 1 9%
Student > Master 1 9%
Unknown 5 45%
Readers by discipline Count As %
Medicine and Dentistry 4 36%
Chemical Engineering 1 9%
Psychology 1 9%
Nursing and Health Professions 1 9%
Unknown 4 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2021.
All research outputs
#16,795,718
of 25,477,125 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#565
of 1,184 outputs
Outputs of similar age
#314,770
of 527,541 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#29
of 67 outputs
Altmetric has tracked 25,477,125 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 527,541 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.